Veeva Systems Inc. Company Analysis & Research
Veeva delivers the industry cloud for life sciences with software, data, and business consulting, serving more than 1,500 customers ranging from the world's largest pharmaceutical companies to emerging biotechs. Their solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations.
Veeva Vault CRM had 23 new customer additions in Q3 with a total of 115 customers live. 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement and provide data for AI globally. The company is navigating competitive pressures but advancing AI initiatives across its product portfolio.
Company Overview
Founded: 2000. Headquarters: Pleasanton, US. Revenue: $3.17B. Ticker: VEEV (NYSE).
Industry
Cloud Software for Life Sciences
Cyborg Score: 7/10 — Solid
Market-leading position in life sciences cloud with strong AI integration strategy, but faces intensifying competition and customer retention headwinds
Veeva demonstrates strong customer acquisition momentum with major enterprise wins and healthy revenue growth at 16% YoY. However, analysts express skepticism over customer retention and competition from Salesforce, creating execution risks despite solid product momentum and AI progress.
Key Strategic Insights for Veeva Systems Inc.
- Q3 FY2026 revenues grew 16% YoY to $811.2M, with subscription revenues up 17% YoY to $682.5M
- Recent strategic wins include long-term partnership with BioMarin announced January 8, 2026 and major enterprise adoption of Veeva Link Key People
- Veeva AI progress with industry-specific agents for CRM and commercial content on track for early December release, with R&D, quality, and additional agents planned for 2026
- Analysts project 10.34% earnings growth year-over-year
Recent Developments
- (Feb 2026) 13 top-20 biopharmas standardized on Veeva Link Key People with 38 new customers added
- (Jan 2026) Long-term strategic partnership with BioMarin and broader Veeva Link Key People adoption
- (Jan 2026) Environmental Monitoring solution announced for manufacturing quality control, planned availability December 2026
- (Jan 2026) Novo Nordisk International Operations committed to Veeva Vault CRM
Competitors & Competitive Landscape
- Salesforce — Enterprise CRM with healthcare extensions
- IQVIA — Clinical research and pharma data services
- Dassault Systèmes — Clinical trial cloud platform
- Microsoft — Industry cloud for pharma and life sciences
Veeva faces competition from Salesforce, which dominates enterprise CRM but lacks specialized life sciences focus. Other competitors include specialized clinical/regulatory software providers and emerging AI-first platforms. Veeva's advantage lies in deep industry specialization and integrated cloud platform combining CRM, clinical, development, and quality functions.
More Company Research
Golden Matrix Group, Inc. Digital Bros Air Asia Company Limited (AACL) Postal Realty Trust, Inc. ArriVent BioPharma, Inc. Kier Group plc Dom Development S.A. Marex Group plc NovaGold Resources Inc. Tokyo Metro Co., Ltd. SBI Cards and Payment Services Limited Wistron Corporation Legrand SA Nikola Corporation Wolftank-Adisa HoldingFull Company Research Reports
Looking for a more in-depth analysis of Veeva Systems Inc.? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, and analyst podcasts.